Brand Name: GefticipIngredient: GefitinibManufacturer: CiplaType: TabletStrength: 250 mgSupply: Pack of 30 tabs
Gefticip - Gefitinib Tablet is indicated as monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies. The offered tablet contains gefitinib as an active ingredient. This tablet works by blocking a protein to inhibit spread and growth of cancer cells. Take as directed by the doctor or follow the direction printed on the product insert. Dosage is based on patients’ condition.